Skip to main content

Abstract

Objective:

Recent evidence supports the use of neuromelanin-sensitive MRI (NM-MRI) as a novel tool to investigate dopamine function in the human brain. The authors investigated the NM-MRI signal in individuals with cocaine use disorder, compared with age- and sex-matched control subjects, based on previous imaging studies showing that this disorder is associated with blunted presynaptic striatal dopamine.

Methods:

NM-MRI and T1-weighted images were acquired from 20 participants with cocaine use disorder and 35 control subjects. Diagnostic group effects in NM-MRI signal were determined using a voxelwise analysis within the substantia nigra. A subset of 20 cocaine users and 17 control subjects also underwent functional MRI imaging using the monetary incentive delay task, in order to investigate whether NM-MRI signal was associated with alterations in reward processing.

Results:

Compared with control subjects, cocaine users showed significantly increased NM-MRI signal in ventrolateral regions of the substantia nigra (area under the receiver operating characteristic curve=0.83). Exploratory analyses did not find a significant correlation of NM-MRI signal to activation of the ventral striatum during anticipation of monetary reward.

Conclusions:

Given that previous imaging studies show decreased dopamine signaling in the striatum, the finding of increased NM-MRI signal in the substantia nigra provides additional insight into the pathophysiology of cocaine use disorder. One interpretation is that cocaine use disorder is associated with a redistribution of dopamine between cytosolic and vesicular pools, leading to increased accumulation of neuromelanin. The study findings thus suggest that NM-MRI can serve as a practical imaging tool for interrogating the dopamine system in addiction.

Formats available

You can view the full content in the following formats:

Supplementary Material

File (appi.ajp.2020.20010090.ds00001.pdf)
File (appi.ajp.2020.20010090.ds001.pdf)

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1038 - 1047
PubMed: 32854531

History

Received: 28 January 2020
Revision received: 26 April 2020
Accepted: 24 June 2020
Published online: 28 August 2020
Published in print: November 01, 2020

Keywords

  1. Cocaine Use Disorder
  2. Substantia Nigra
  3. Neuromelanin-Sensitive MRI
  4. Dopamine

Authors

Affiliations

Clifford M. Cassidy, Ph.D. [email protected]
University of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Kenneth M. Carpenter, Ph.D.
University of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Anna B. Konova, Ph.D.
University of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Victoria Cheung, B.Sc.
University of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Alexander Grassetti, B.A.
University of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Luigi Zecca, M.D., Ph.D.
University of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Anissa Abi-Dargham, M.D.
University of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Diana Martinez, M.D.
University of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Guillermo Horga, M.D., Ph.D.
University of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).

Notes

Send correspondence to Dr. Cassidy ([email protected]).

Author Contributions

Drs. Martinez and Horga contributed equally to this study.

Competing Interests

The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH.

Funding Information

Supported by NIDA grant R01 DA020855 (to Dr. Martinez and Carpenter) and by NIMH grants R01 MH117323 and R01 MH114965 (to Dr. Horga). Additional support was received from NIH’s National Center for Advancing Translational Sciences through grant UL1TR001873.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share